Pfizer's share price has almost halved since its 2022 peak and is now down to pre-pandemic 5-year lows. In this analysis, we take a look at why the Pfizer share price is so low and where it may be at the end of the decade.
2030 might sound like a long time into the future, but the new decade will start in less than 6 years which for long-term in...
Get unlimited access to the Good Money Guide expert analysis
Become a better, more informed investor with Good Money Guide. Our expert exclusive analysis provides the sort of information that everyone, from first-time investors to experienced professional traders, can learn to profit from.
Monthly
Premium
£
4
99
Monthly -
Broker Comparison
-
Expert Market Analysis
-
Buy & Sell Ratings
-
Investing Indicators
-
Educational Courses
-
Exclusive Event Invites
Pay Monthly
Cancel anytime
Yearly
Premium
£
49
Yearly
-
Save 15%
-
14-Day Money Back Guarantee
-
Broker Comparison
-
Expert Market Analysis
-
Buy & Sell Ratings
-
Investing Indicators
-
Educational Courses
-
Exclusive Event Invites
Pay Yearly
Cancel anytime
Save 15%